Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Levodropropizine
Cat. No.:
OB0225LY-0138
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Levodropropizine is a histamine receptor inhibitor with peripheral effects.
Synonym:
(S)-(-)-Dropropizine; DF-526; 99291-25-5; (S)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol; (-)-Dropropizine; (2S)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol; (-)-(S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol; 1,2-Propanediol, 3-(4-phenyl-1-piperazinyl)-, (2S)-; S(-)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol; S-(-)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol; (2S)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol
CAS No.:
99291-25-5
Compound CID:
65859
Formula:
C13H20N2O2
Formula Weight:
236.31
Specification
Relative Density:
1.168 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Levodropropizine can be used to relieve dry cough and is commonly used in respiratory disease research.
Library Information
Targets:
Histamine receptor family; 5-HT receptor family
Pathways:
Neuronal signaling; Immunology/Inflammation; GPCR/G protein
Plate Number:
AOCL-2
Plate Location:
f11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 232.75 mM
Water Max Solubility:
12 mg/mL; 50.8 mM
Ethanol Max Solubility:
44 mg/mL; 186.2 mM
